Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2025-02-06 Capital/Financing Update
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the launch of a new entity in Spain by Indegene Limited. It is addressed to stock exchanges pursuant to a regulatory disclosure requirement (Regulation 30 of SEBI LODR), but it does not contain financial data, management discussion, or detailed report content. It is an announcement of a corporate development event, specifically an expansion and new entity launch, rather than a financial report, earnings release, or management report. The document is about a business update and strategic expansion, which fits best under Capital/Financing Update (CAP) as it relates to company growth and operational footprint expansion. The document length is about 5257 characters, which is sufficient for a press release but not a full report. Therefore, the most appropriate classification is CAP with high confidence.
2025-02-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of the Q3FY25 earnings call. It references the SEBI regulations and provides a link to the audio recording rather than the transcript itself. The document is short (1420 characters) and serves as an announcement of the availability of the earnings call recording, not the transcript or detailed financial results. Therefore, it is not a Call Transcript (CT) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as it is a general regulatory announcement about the earnings call recording availability.
2025-01-31 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the opening of the trading window for insiders to deal in the company's securities, pursuant to SEBI regulations and the company's code of conduct. It references the upcoming approval and declaration of financial results for the quarter ended December 31, 2024, but does not contain any financial data or results itself. The document is only 1666 characters long and serves as an announcement related to insider trading compliance rather than a financial report or earnings release. Therefore, it does not fit categories like Earnings Release (ER) or Interim Report (IR). It is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-01-31 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated January 31, 2025, regarding the publication of financial results for the quarter ended December 31, 2024. It mentions the newspaper advertisement of the financial results and compliance with SEBI regulations. The document does not contain detailed financial statements or substantive financial data but rather informs about the publication of the financial results advertisement in newspapers and on the company's website. The length is about 15,000 characters, but the content is primarily an announcement of the financial results advertisement, not the full quarterly report itself. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the financial results publication, not the actual Interim/Quarterly Report (IR) or Earnings Release (ER).
2025-01-31 English
Change in Auditors
Regulatory Filings Classification · 95% confidence The document is an official notification from the company to stock exchanges about the recommendation of appointment of a new statutory auditor. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and details about the auditor's term and profile. The document does not contain any financial statements or audit results but is an announcement of a board decision regarding auditor appointment. The document length is 3364 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this fits best under Regulatory Filings (RNS) as it is a regulatory announcement about auditor appointment, not the audit report itself.
2025-01-30 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is an analyst presentation and fact sheet on financial results for the quarter ended December 31, 2024 (Q3FY25). It includes detailed financial highlights, segment performance, management commentary, and business updates. The document is about 15,000 characters long, contains substantive financial data and analysis, and is not merely an announcement or a certification. The presence of detailed quarterly financial data and management discussion indicates it is a comprehensive interim/quarterly report rather than just an earnings release or a brief fact sheet. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2025-01-30 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.